Editas Medicine, Inc.

Editas Medicine, Inc.verified

EDIT

Price:

$1.25

Market Cap:

$103.19M

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads to inherited childhood blindness. It also develops EDIT-102 for the treatment of Usher Syndrome 2A, which is a form of retinitis pigmentosa that also includes hearing loss; autosomal dominant retinitis pigmentosa, a progressive form of retinal degeneration; and EDIT-301 to treat sickle cell disease and transfusion-dependent beta-thalassemia. In additio...[Read more]

Industry

Biotechnology

IPO Date

2016-02-03

Stock Exchange

NASDAQ

Ticker

EDIT

The Enterprise Value as of December 2024 (TTM) for Editas Medicine, Inc. (EDIT) is 45.84M

According to Editas Medicine, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 45.84M. This represents a change of -90.24% compared to the average of 469.92M of the last 4 quarters.

Editas Medicine, Inc. (EDIT) Historical Enterprise Value (quarterly & annually)

How has EDIT Enterprise Value performed in the past?

The mean historical Enterprise Value of Editas Medicine, Inc. over the last ten years is 1.15B. The current 45.84M Enterprise Value has changed 297.80% with respect to the historical average. Over the past ten years (40 quarters), EDIT's Enterprise Value was at its highest in in the December 2020 quarter at 4.24B. The Enterprise Value was at its lowest in in the December 2014 quarter at 63.29M.

Quarterly (TTM)
Annual

Average

1.15B

Median

837.79M

Minimum

270.81M

Maximum

4.00B

Editas Medicine, Inc. (EDIT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Editas Medicine, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 4.76%

Maximum Annual Enterprise Value = 4.00B

Minimum Annual Increase = -68.39%

Minimum Annual Enterprise Value = 270.81M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023682.42M33.42%
2022511.48M-68.39%
20211.62B-59.50%
20204.00B214.39%
20191.27B31.14%
2018969.11M-13.93%
20171.13B202.11%
2016372.70M-47.24%
2015706.47M160.87%
2014270.81M4.76%

Editas Medicine, Inc. (EDIT) Average Enterprise Value

How has EDIT Enterprise Value performed in the past?

The current Enterprise Value of Editas Medicine, Inc. (EDIT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

937.35M

5-year avg

1.62B

10-year avg

1.15B

Editas Medicine, Inc. (EDIT) Enterprise Value vs. Peers

How is EDIT’s Enterprise Value compared to its peers?

Editas Medicine, Inc.’s Enterprise Value is less than Beam Therapeutics Inc. (2.31B), less than CRISPR Therapeutics AG (3.46B), less than Caribou Biosciences, Inc. (156.76M), less than Verve Therapeutics, Inc. (412.06M), less than Intellia Therapeutics, Inc. (1.21B), less than Prime Medicine, Inc. (291.83M), less than Vertex Pharmaceuticals Incorporated (100.83B), less than Ginkgo Bioworks Holdings, Inc. (373.13M), less than Allogene Therapeutics, Inc. (442.76M), less than Sana Biotechnology, Inc. (333.02M),

Build a custom stock screener for Editas Medicine, Inc. (EDIT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Editas Medicine, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Editas Medicine, Inc. (EDIT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Editas Medicine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Editas Medicine, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Editas Medicine, Inc. (EDIT)?

What is the 3-year average Enterprise Value for Editas Medicine, Inc. (EDIT)?

What is the 5-year average Enterprise Value for Editas Medicine, Inc. (EDIT)?

How does the current Enterprise Value for Editas Medicine, Inc. (EDIT) compare to its historical average?